Study Finds β-Blockers May Not Reduce Cardiovascular Event Risk

Findings in observational study of stable patients with, without coronary artery disease, prior MI

TUESDAY, Oct. 2 (HealthDay News) -- For patients with coronary artery disease (CAD) risk factors alone, previous myocardial infarction (MI), or CAD without MI, β-blockers are not associated with a lower rate of cardiovascular events, according to a study published in the Oct. 3 issue of the Journal of the American Medical Association.

Sripal Bangalore, M.D., M.H.A., from the New York University School of Medicine in New York City, and colleagues assessed the correlation between β-blocker use and cardiovascular events in three groups of patients in the Reduction of Atherothrombosis for Continued Health registry: 14,043 with known prior MI; 12,012 with known CAD without MI; and 18,653 with CAD risk factors alone. A composite of cardiovascular death, nonfatal MI, or nonfatal stroke was the primary outcome. The primary outcome plus hospitalization for atherothrombotic events or revascularization procedure was assessed as the secondary outcome.

The researchers found that, over 44 months, event rates were not significantly different in patients using β-blockers versus those without β-blockers, even in the prior MI cohort. In the CAD without MI cohort, there were significantly higher rates for the secondary outcome with β-blocker use (odds ratio [OR], 1.14) and for the tertiary outcome (OR, 1.17). In patients with CAD risk factors only, the event rates were significantly higher for both the primary outcome (hazard ratio, 1.18) and the secondary outcome (OR, 1.12) with β-blocker use versus without. β-blocker use correlated with a significantly lower incidence of the secondary outcome (OR, 0.77) for those with recent MI (no more than one year).

"Further research is warranted to identify subgroups that benefit from β-blocker therapy and the optimal duration of β-blocker therapy," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles

Blunt Chest Trauma
Journal of Trauma Nursing, November/December 2014
Expires: 12/31/2016 CE:2 $21.95

The School Age Child with Congenital Heart Disease
MCN, The American Journal of Maternal/Child Nursing, January/February 2015
Expires: 2/28/2017 CE:2.5 $24.95

Understanding multiple myeloma
Nursing Made Incredibly Easy!, January/February 2015
Expires: 2/28/2017 CE:2 $21.95

More CE Articles

Subscribe to Recommended CE

Recommended Nursing Articles

Comprehensive Care: Looking Beyond the Presenting Problem
Journal of Christian Nursing, January/March 2015
Free access will expire on March 2, 2015.

Pain and Alzheimer dementia: A largely unrecognized problem
Nursing Made Incredibly Easy!, January/February 2015
Free access will expire on February 16, 2015.

Glycemic control in hospitalized patients
Nursing2015 Critical Care, January 2015
Free access will expire on February 16, 2015.

More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events